In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...

It's been one week since Wanda Lee-Ballou received University of Virginia (UVA) Health's first dose of Ocravus Zunovo – the ...

What used to take hours, we can now do in less than 30 minutes”: FDA OKs new treatment for people suffering from multiple ...

Changes in the gene activity of immune cells may help flag people who have multiple sclerosis or are likely to develop it, a ...

Sir Chris Hoy has confirmed that his cancer his terminal but his wife, Sarra, is also battling aggressive multiple sclerosis ...

Researchers ... New Study Finds a Promising Combined Therapy for Multiple Sclerosis Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS ...

A recent study showed that both cognitive behavioral therapy (CBT) and the mild stimulant modafinil (Provigil) reduced MS ...

Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

The COMBO-MS trial, reported in The Lancet Neurology by Tiffany Braley and colleagues,1 is the first pragmatic, randomised, controlled trial that compares head-to-head the benefits and harms of a ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...

Curiously, columnist Leigh Anne Nelson can't tolerate wearing socks. It's one of several foot symptoms of her MS.

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...